Does RESLIZUMAB Cause Myalgia? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Myalgia have been filed in association with RESLIZUMAB (CINQAIR). This represents 4.7% of all adverse event reports for RESLIZUMAB.
29
Reports of Myalgia with RESLIZUMAB
4.7%
of all RESLIZUMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Myalgia From RESLIZUMAB?
Of the 29 reports, 1 (3.4%) resulted in death, 3 (10.3%) required hospitalization, and 1 (3.4%) were considered life-threatening.
Is Myalgia Listed in the Official Label?
Yes, Myalgia is listed as a known adverse reaction in the official FDA drug label for RESLIZUMAB.
What Other Side Effects Does RESLIZUMAB Cause?
Dyspnoea (86)
Asthma (82)
Drug ineffective (80)
Incorrect dose administered (63)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which RESLIZUMAB Alternatives Have Lower Myalgia Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN